| Carolyn Sheils, CCC-SLP | |
|
645 Baltimore Annapolis Blvd, Suite 111, Severna Park, MD 21146-3931 | |
| (410) 544-2500 | |
| (410) 384-9703 |
| Full Name | Carolyn Sheils |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 645 Baltimore Annapolis Blvd, Severna Park, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417254368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn Sheils, CCC-SLP 645 Baltimore Annapolis Blvd, Suite 111, Severna Park, MD 21146-3931 Ph: (410) 544-2500 | Carolyn Sheils, CCC-SLP 645 Baltimore Annapolis Blvd, Suite 111, Severna Park, MD 21146-3931 Ph: (410) 544-2500 |
News Archive
ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at poster sessions at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009.
Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
Prestige Brands Holdings, Inc. today announced results for the fiscal 2012 third quarter ended December 31, 2011, including net revenues of $106.3 million, an increase of 17.3% over the prior year's comparable quarter of $90.6 million.
Quest Diagnostics, the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2015 Supplier Forum.
› Verified 4 days ago
Miss Kaitlyn Ashley Sikkema, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Mrs. Nancy Beasley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 | |
Lisa J Remer, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Truck House Rd, Severna Park, MD 21146 Phone: 410-544-4220 Fax: 410-647-9484 | |
Amy Curtin, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 645 Baltimore Annapolis Blvd Ste 212, Severna Park, MD 21146 Phone: 410-544-2500 | |
Francis Nochera Iv, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 Baltimore Annapolis Blvd, Severna Park, MD 21146 Phone: 410-647-1503 | |
Mrs. Kara Lynn Rice, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Christina T Whitlock, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 |